A detailed history of United Capital Financial Advisers, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 203,781 shares of ABBV stock, worth $33.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
203,781
Previous 204,382 0.29%
Holding current value
$33.6 Million
Previous $35.1 Million 14.8%
% of portfolio
0.2%
Previous 0.3%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $98,467 - $119,797
-601 Reduced 0.29%
203,781 $40.2 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $8.76 Million - $10.2 Million
-56,592 Reduced 21.68%
204,382 $35.1 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $3.39 Million - $3.86 Million
-21,222 Reduced 7.52%
260,974 $47.5 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $15 Million - $16.9 Million
-108,965 Reduced 27.86%
282,196 $43.7 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $4.36 Million - $5.05 Million
-32,642 Reduced 7.7%
391,161 $58.3 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $9.85 Million - $12.3 Million
-74,357 Reduced 14.93%
423,803 $57.1 Million
Q1 2023

Aug 14, 2023

BUY
$144.61 - $166.54 $5.35 Million - $6.16 Million
36,971 Added 8.72%
460,774 $73.4 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $2.52 Million - $2.9 Million
17,400 Added 3.62%
498,160 $79.4 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $3.21 Million - $3.85 Million
-23,233 Reduced 4.61%
480,760 $77.7 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $7.92 Million - $9.08 Million
-58,990 Reduced 10.48%
503,993 $67.6 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $7.68 Million - $9.76 Million
55,809 Added 11.0%
562,983 $86.2 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $34,314 - $42,575
-260 Reduced 0.05%
507,174 $82.2 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $539,513 - $682,640
-5,022 Reduced 0.98%
507,434 $68.7 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $1.03 Million - $1.17 Million
-9,723 Reduced 1.86%
512,456 $55.3 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $1.38 Million - $1.54 Million
13,104 Added 2.57%
522,179 $58.8 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $1.69 Million - $1.86 Million
-16,534 Reduced 3.15%
509,075 $55.1 Million
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $1.51 Million - $2.04 Million
18,804 Added 3.71%
525,609 $56.3 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $243,383 - $285,651
-2,833 Reduced 0.56%
506,805 $44.4 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $282,841 - $378,483
-3,855 Reduced 0.75%
509,638 $50 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $1.14 Million - $1.72 Million
-17,597 Reduced 3.31%
513,493 $39.1 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $1.32 Million - $1.65 Million
18,249 Added 3.56%
531,090 $47 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $4.32 Million - $5.2 Million
68,622 Added 15.45%
512,841 $38.8 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $1.17 Million - $1.49 Million
17,760 Added 4.16%
444,219 $32.3 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $691,714 - $814,113
-8,967 Reduced 2.06%
426,459 $34.4 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $597,732 - $737,164
7,678 Added 1.79%
435,426 $40.1 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $477,535 - $530,869
-5,371 Reduced 1.24%
427,748 $40.5 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $173,903 - $205,767
-1,937 Reduced 0.45%
433,119 $40.1 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $40 Million - $53.6 Million
435,056 New
435,056 $41.2 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $39.6 Million - $43.5 Million
-442,424 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $247,268 - $315,838
3,540 Added 0.81%
442,424 $39.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
438,884
438,884 $31.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.